We previously showed that NIPBL transcript abundance is decreased in AML patients carrying the mutated NUCLEOPHOSMIN1 (NPM1), which transfers NPM1 in the cytoplasm (NPMc+), compared to the NPM1 wild‐type (NPM1wt).34 This evidence concerns the gene NPM1 and acute myeloid leukemia.